Drug
Dextromethorphan Bupropion
Dextromethorphan Bupropion: highest development phase Phase 2, developed by Axsome Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Axsome Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dextromethorphan-Bupropion NCT07523048 | Phase 2 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Dextromethorphan Bupropion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.